SAM
CYTK icon

Sectoral Asset Management’s Cytokinetics CYTK Stock Holding History

Sectoral Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
16,330
+9,030
+124% +$648K 0.97% 36
2026
Q1 		$545K Buy
7,300
+1,407
+24% +$89.4K 0.45% 55
2025
Q4 		$374K Sell
5,893
-4,330
-42% -$269K 0.3% 64
2025
Q3 		$562K Sell
10,223
-1,500
-13% -$61.8K 0.35% 64
2025
Q2 		$387K Sell
11,723
-6,345
-35% -$221K 0.26% 74
2025
Q1 		$726K Sell
18,068
-6,432
-26% -$296K 0.57% 44
2024
Q4 		$1.15M Sell
24,500
-4,093
-14% -$213K 0.77% 35
2024
Q3 		$1.51M Sell
28,593
-8,290
-22% -$462K 0.89% 33
2024
Q2 		$2M Sell
36,883
-5,700
-13% -$344K 0.81% 39
2024
Q1 		$2.99M Buy
42,583
+35,570
+507% +$2.75M 1.17% 24
2023
Q4 		$586K Sell
7,013
-111,290
-94% -$4.03M 0.25% 71
2023
Q3 		$3.49M Buy
118,303
+1,220
+1% +$40.6K 0.68% 63
2023
Q2 		$3.82M Buy
117,083
+33,233
+40% +$1.23M 0.64% 66
2023
Q1 		$2.95M Buy
83,850
+400
+0.5% +$16.3K 0.57% 72
2022
Q4 		$3.82M Hold
83,450
– – 0.74% 58
2022
Q3 		$4.04M Sell
83,450
-550
-0.7% -$26.5K 0.8% 58
2022
Q2 		$3.3M Buy
84,000
+14,000
+20% +$564K 0.66% 62
2022
Q1 		$2.58M Buy
+70,000
New +$2.49M 0.46% 73
2019
Q2 		– Sell
-15,582
Closed -$126K – 95
2019
Q1 		$126K Hold
15,582
– – 0.02% 96
2018
Q4 		$98K Hold
15,582
– – 0.01% 93
2018
Q3 		$153K Buy
+15,582
New +$125K 0.02% 147

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sectoral Asset Management's CYTK Position: Q2 2026 in Review

Sectoral Asset Management increased its Cytokinetics (CYTK) stake by 124% in Q2 2026, buying an estimated $648K and bringing the position to 16,330 shares worth $1.39M. The position accounts for 0.97% of the portfolio, ranked #36.

Sectoral Asset Management first reported a position in CYTK in Q3 2018 and has held it in 21 quarters since. The position peaked at $4.04M in Q3 2022. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Sectoral Asset Management held 16,330 shares of Cytokinetics worth $1.39M as of Q2 2026.
  • Sectoral Asset Management bought 9,030 Cytokinetics shares in Q2 2026, an estimated $648K.
  • Cytokinetics made up 0.97% of Sectoral Asset Management's portfolio in Q2 2026, its #36 holding.
  • Sectoral Asset Management first reported a position in Cytokinetics in Q3 2018 and has held it in 21 quarters since.
  • Sectoral Asset Management's Cytokinetics position peaked at $4.04M in Q3 2022.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.